Brief: Amoeba FY Operating Loss Narrows To EUR 5.6 Million

Amoeba SA

31/03/2022 16:58

March 31 (Reuters) - Amoeba SA  ALMIB.PA :
    * AMOEBA 2021 RESULTS: CONTINUED DEVELOPMENT OF BIOCIDAL AND
BIOCONTROL APPLICATIONS
    * FY NET LOSS EUR 7.8 MILLION VERSUS LOSS EUR 8.2 MILLION
YEAR AGO
    * FY OPERATING LOSS EUR 5.6 MILLION VERSUS LOSS EUR 6.2
MILLION
YEAR AGO
    * COMPANY HAS SUFFICIENT NET WORKING CAPITAL TO MEET
OBLIGATIONS
AND CASH REQUIREMENTS OVER NEXT 12 MONTHS, BELIEVING IT CAN MEET
COMMITMENTS MADE UNTIL DECEMBER 2023
    * COMPANY IS PREPARING TO CARRY OUT A NEW CAMPAIGN OF FIELD
TESTS
OF ITS BIOCONTROL PRODUCT
    * AT 31 DECEMBER 2021, THE COMPANY'S EQUITY WAS €0.2M
COMPARED TO
€2M AT 31 DECEMBER 2020
    * END-DEC FINANCIAL DEBT OF COMPANY AMOUNTS TO 12.5 M€

Source text for Eikon:  ID:nNDL8xXL1V 
Further company coverage:  ALMIB.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))